Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Methods to improve quality performance at scale in lower- and middle-income countries.

Fritsche G, Peabody J.

J Glob Health. 2018 Dec;8(2):021002. doi: 10.7189/jogh.08.021002.

2.

[Relaxation techniques and behavioural therapy for the treatment of migraine : Guidelines from the German Migraine and Headache Society].

Kropp P, Meyer B, Dresler T, Fritsche G, Gaul C, Niederberger U, Förderreuther S, Malzacher V, Jürgens TP, Marziniak M, Straube A.

Schmerz. 2017 Oct;31(5):433-447. doi: 10.1007/s00482-017-0214-1. German.

PMID:
28364171
3.

Integrated multidisciplinary care of headache disorders: A narrative review.

Gaul C, Liesering-Latta E, Schäfer B, Fritsche G, Holle D.

Cephalalgia. 2016 Oct;36(12):1181-1191. doi: 10.1177/0333102415617413. Epub 2016 Jul 11. Review.

PMID:
26646785
4.

Performance-based financing as a health system reform: mapping the key dimensions for monitoring and evaluation.

Witter S, Toonen J, Meessen B, Kagubare J, Fritsche G, Vaughan K.

BMC Health Serv Res. 2013 Sep 29;13:367. doi: 10.1186/1472-6963-13-367.

5.

[Psychological therapy of migraine: systematic review].

Fritsche G, Kröner-Herwig B, Kropp P, Niederberger U, Haag G.

Schmerz. 2013 Jun;27(3):263-74. doi: 10.1007/s00482-013-1319-9. Review. German.

PMID:
23685993
6.

Chronic migraine and chronic tension-type headache are associated with concomitant low back pain: results of the German Headache Consortium study.

Yoon MS, Manack A, Schramm S, Fritsche G, Obermann M, Diener HC, Moebus S, Katsarava Z.

Pain. 2013 Mar;154(3):484-92. doi: 10.1016/j.pain.2012.12.010. Epub 2012 Dec 28.

PMID:
23375162
7.

Time for innovative dialogue on health systems research.

Meessen B, van Heteren G, Soeters R, Fritsche G, van Damme W.

Bull World Health Organ. 2012 Oct 1;90(10):715-715A. doi: 10.2471/BLT.12.112326. No abstract available.

8.

Slc11a1 (Nramp1) impairs growth of Salmonella enterica serovar typhimurium in macrophages via stimulation of lipocalin-2 expression.

Fritsche G, Nairz M, Libby SJ, Fang FC, Weiss G.

J Leukoc Biol. 2012 Aug;92(2):353-9. doi: 10.1189/jlb.1111554. Epub 2012 Jun 15.

9.

Prevalence of primary headaches in Germany: results of the German Headache Consortium Study.

Yoon MS, Katsarava Z, Obermann M, Fritsche G, Oezyurt M, Kaesewinkel K, Katsarova A, Santowski I, Diener H, Moebus S.

J Headache Pain. 2012 Apr;13(3):215-23. doi: 10.1007/s10194-012-0425-x. Epub 2012 Mar 7.

10.

Evaluating integrated headache care: a one-year follow-up observational study in patients treated at the Essen headache centre.

Gaul C, Brömstrup J, Fritsche G, Diener HC, Katsarava Z.

BMC Neurol. 2011 Oct 10;11:124. doi: 10.1186/1471-2377-11-124.

11.

Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study.

Gaul C, van Doorn C, Webering N, Dlugaj M, Katsarava Z, Diener HC, Fritsche G.

J Headache Pain. 2011 Aug;12(4):475-83. doi: 10.1007/s10194-011-0348-y. Epub 2011 May 5.

12.

Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria.

Poeppl W, Hell M, Herkner H, Stoiser B, Fritsche G, Schurz-Bamieh N, Poeppl G, Gattringer R, Jones N, Maass M, Egle A, Burgmann H.

Infection. 2011 Aug;39(4):341-52. doi: 10.1007/s15010-011-0121-9. Epub 2011 May 5.

PMID:
21544585
13.

Prevention of medication overuse in patients with migraine.

Fritsche G, Frettlöh J, Hüppe M, Dlugaj M, Matatko N, Gaul C, Diener HC; Study Group.

Pain. 2010 Nov;151(2):404-13. doi: 10.1016/j.pain.2010.07.032. Epub 2010 Aug 30.

PMID:
20800968
14.

Health sector recovery in early post-conflict environments: experience from southern Sudan.

Cometto G, Fritsche G, Sondorp E.

Disasters. 2010 Oct;34(4):885-909. doi: 10.1111/j.1467-7717.2010.01174.x.

PMID:
20561340
15.

Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2.

Nairz M, Theurl I, Schroll A, Theurl M, Fritsche G, Lindner E, Seifert M, Crouch ML, Hantke K, Akira S, Fang FC, Weiss G.

Blood. 2009 Oct 22;114(17):3642-51. doi: 10.1182/blood-2009-05-223354. Epub 2009 Aug 21.

16.

Slc11a1 limits intracellular growth of Salmonella enterica sv. Typhimurium by promoting macrophage immune effector functions and impairing bacterial iron acquisition.

Nairz M, Fritsche G, Crouch ML, Barton HC, Fang FC, Weiss G.

Cell Microbiol. 2009 Sep;11(9):1365-81. doi: 10.1111/j.1462-5822.2009.01337.x. Epub 2009 Jun 2.

17.

Nramp1-functionality increases iNOS expression via repression of IL-10 formation.

Fritsche G, Nairz M, Werner ER, Barton HC, Weiss G.

Eur J Immunol. 2008 Nov;38(11):3060-7. doi: 10.1002/eji.200838449.

18.

Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium.

Nairz M, Fritsche G, Brunner P, Talasz H, Hantke K, Weiss G.

Eur J Immunol. 2008 Jul;38(7):1923-36. doi: 10.1002/eji.200738056.

19.

Population-based validation of a German-language self-administered headache questionnaire.

Yoon MS, Obermann M, Fritsche G, Slomke M, Dommes P, Schilf C, Diener HC, Katsarava Z.

Cephalalgia. 2008 Jun;28(6):605-8. doi: 10.1111/j.1468-2982.2008.01560.x. Epub 2008 Apr 16.

PMID:
18422724
20.

Modulation of macrophage iron transport by Nramp1 (Slc11a1).

Fritsche G, Nairz M, Theurl I, Mair S, Bellmann-Weiler R, Barton HC, Weiss G.

Immunobiology. 2007;212(9-10):751-7. Epub 2007 Nov 14.

PMID:
18086376
21.

Validation of a Georgian language headache questionnaire in a population-based sample.

Kukava M, Dzagnidze A, Janelidze M, Mirvelashvili E, Djibuti M, Fritsche G, Jensen R, Stovner LJ, Steiner TJ, Katsarava Z.

J Headache Pain. 2007 Dec;8(6):321-4. Epub 2007 Dec 10. Erratum in: J Headache Pain. 2008 Apr;9(2):137. Janelidze, Marina [added].

22.

The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium.

Nairz M, Theurl I, Ludwiczek S, Theurl M, Mair SM, Fritsche G, Weiss G.

Cell Microbiol. 2007 Sep;9(9):2126-40. Epub 2007 Apr 25.

PMID:
17466014
23.

Validation of a german language questionnaire for screening for migraine, tension-type headache, and trigeminal autonomic cephalgias.

Fritsche G, Hueppe M, Kukava M, Dzagnidze A, Schuerks M, Yoon MS, Diener HC, Katsarava Z.

Headache. 2007 Apr;47(4):546-51.

PMID:
17445104
24.

Large-scale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancer.

Berger AP, Deibl M, Strasak A, Bektic J, Pelzer AE, Klocker H, Steiner H, Fritsche G, Bartsch G, Horninger W.

Urology. 2007 Jan;69(1):134-8.

PMID:
17270635
25.

Relapse after radical prostatectomy correlates with preoperative PSA velocity and tumor volume: results from a screening population.

Berger AP, Deibl M, Strasak A, Bektic J, Pelzer A, Steiner H, Spranger R, Fritsche G, Bartsch G, Horninger W.

Urology. 2006 Nov;68(5):1067-71. Epub 2006 Nov 7.

PMID:
17095070
26.

Atherosclerosis as a risk factor for benign prostatic hyperplasia.

Berger AP, Bartsch G, Deibl M, Alber H, Pachinger O, Fritsche G, Rantner B, Fraedrich G, Pallwein L, Aigner F, Horninger W, Frauscher F.

BJU Int. 2006 Nov;98(5):1038-42. Epub 2006 Jul 28.

27.

Giorgio's paradox.

Fritsche G.

Lancet. 2005 Oct 15-21;366(9494):1358. No abstract available.

PMID:
16226612
28.

Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction.

Berger AP, Deibl M, Leonhartsberger N, Bektic J, Horninger W, Fritsche G, Steiner H, Pelzer AE, Bartsch G, Frauscher F.

BJU Int. 2005 Nov;96(7):1073-8.

29.

The macrophage: a cellular factory at the interphase between iron and immunity for the control of infections.

Theurl I, Fritsche G, Ludwiczek S, Garimorth K, Bellmann-Weiler R, Weiss G.

Biometals. 2005 Aug;18(4):359-67. Review. No abstract available.

PMID:
16158228
30.

Suprapubic electroresection of prostate in three patients with benign prostatic hyperplasia and previous surgery for long urethral stricture.

Berger AP, Horninger W, Rehder P, Tosun K, Fritsche G, Bartsch G, Gozzi C.

Urology. 2005 Apr;65(4):798.

PMID:
15833539
31.

Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.

Berger AP, Deibl M, Halpern EJ, Lechleitner M, Bektic J, Horninger W, Fritsche G, Steiner H, Pelzer A, Bartsch G, Frauscher F.

Diabetologia. 2005 Apr;48(4):784-9. Epub 2005 Mar 9.

PMID:
15756540
32.

Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.

Molnar C, Garcia-Trevijano ER, Ludwiczek O, Talabot D, Kaser A, Mato JM, Fritsche G, Weiss G, Gabay C, Avila MA, Tilg H.

Eur Cytokine Netw. 2004 Oct-Dec;15(4):303-11.

33.

Medication overuse headache: rates and predictors for relapse in a 4-year prospective study.

Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V.

Cephalalgia. 2005 Jan;25(1):12-5.

PMID:
15606564
34.

[Gordian knot: medication overuse headache].

Katsarava Z, Fritsche G.

Schmerz. 2004 Oct;18(5):421-3. Review. German.

PMID:
15322884
35.

Large-vessel arteritis and myelodysplastic syndrome: report of two cases.

Steurer M, Fritsche G, Tzankov A, Gotwald T, Sturm W, Konwalinka G, Gruber J.

Eur J Haematol. 2004 Aug;73(2):128-33.

PMID:
15245512
36.

Incidence and predictors for chronicity of headache in patients with episodic migraine.

Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V.

Neurology. 2004 Mar 9;62(5):788-90.

PMID:
15007133
37.

Medication overuse headaches -- what is new?

Fritsche G, Diener HC.

Expert Opin Drug Saf. 2002 Nov;1(4):331-8. Review.

PMID:
12904133
38.

Nramp1 functionality increases inducible nitric oxide synthase transcription via stimulation of IFN regulatory factor 1 expression.

Fritsche G, Dlaska M, Barton H, Theurl I, Garimorth K, Weiss G.

J Immunol. 2003 Aug 15;171(4):1994-8.

39.

[Psychological descriptors of excessive use of analgesic medication].

Fritsche G, Nitsch C, Pietrowsky R, Diener HC.

Schmerz. 2000 Aug;14(4):217-25. German.

PMID:
12800027
40.

Rates and predictors for relapse in medication overuse headache: a 1-year prospective study.

Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G.

Neurology. 2003 May 27;60(10):1682-3.

PMID:
12771266
41.

The management of chronic tinnitus: comparison of an outpatient cognitive-behavioral group training to minimal-contact interventions.

Kröner-Herwig B, Frenzel A, Fritsche G, Schilkowsky G, Esser G.

J Psychosom Res. 2003 Apr;54(4):381-9.

PMID:
12670617
42.

Features of medication overuse headache following overuse of different acute headache drugs.

Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC.

Neurology. 2002 Oct 8;59(7):1011-4.

PMID:
12370454
43.

Effects of synthetic siderophores on proliferation of Plasmodium falciparum in infected human erythrocytes.

Rotheneder A, Fritsche G, Heinisch L, Möllmann U, Heggemann S, Larcher C, Weiss G.

Antimicrob Agents Chemother. 2002 Jun;46(6):2010-3.

44.

Controlling humanitarian aid cowboys in Afghanistan.

Fritsche G.

Lancet. 2001 Dec 8;358(9297):2002. No abstract available.

PMID:
11747963
45.

Clinical features of withdrawal headache following overuse of triptans and other headache drugs.

Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V.

Neurology. 2001 Nov 13;57(9):1694-8.

PMID:
11706113
46.

Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse.

Fritsche G, Eberl A, Katsarava Z, Limmroth V, Diener HC.

Eur Neurol. 2001;45(4):229-35.

PMID:
11385260
47.

Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection.

Fritsche G, Larcher C, Schennach H, Weiss G.

J Infect Dis. 2001 May 1;183(9):1388-94. Epub 2001 Mar 23.

PMID:
11294671
48.

Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.

Limmroth V, Kazarawa Z, Fritsche G, Diener HC.

Lancet. 1999 Jan 30;353(9150):378. No abstract available.

PMID:
9950449
49.

The physiological stress response and the role of cognitive coping in migraine patients and non-headache controls.

Kröner-Herwig B, Fritsche G, Brauer H.

J Psychosom Res. 1993 Jul;37(5):467-80.

PMID:
8350289
50.

Specificities of monoclonal antibodies B-ly7 and HML-1 are identical.

Schwarting R, Dienemann D, Kruschwitz M, Fritsche G, Stein H.

Blood. 1990 Jan 1;75(1):320-1. No abstract available.

Supplemental Content

Loading ...
Support Center